Adamis Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Update
SAN DIEGO, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today announced financial results for the second quarter ended June 30, 2018 and a business update. Dr. Dennis J. Carlo, President and Chie.....»»

Adamis Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Update
SAN DIEGO, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today announced financial results for the second quarter ended June 30, 2018 and a business update. Dr. Dennis J. Carlo, President and Chie.....»»
Adamis Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -.....»»
Progenics Pharmaceuticals Announces Third Quarter 2018 Financial Results And Business Update
AZEDRA® (iobenguane I 131) Approved by U.S. Food and Drug Administration (FDA) AZEDRA U.S. Launch Progressing and AZEDRA Added.....»»
Progenics Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update
Pre-Commercial Launch Preparations Underway for AZEDRA® (iobenguane I 131) ahead of U.S. Food and Drug Administration (FDA) July 30th Action Date Top-Line Data from Phase 3 Trial .....»»
Unifi Provides Preliminary Second Quarter Business Update and Announces Second Quarter Fiscal 2019 Earnings Conference Call
GREENSBORO, N.C., Jan. 14, 2019 /PRNewswire/ -- Unifi, Inc. (NYSE:UFI), one of the world's leading innovators in synthetic and recycled yarns, today announced preliminary financial results for its second fiscal quarter ended December 30, 2018. F.....»»
Merus Announces Financial Results for the Third Quarter 2018 and Provides Business Update
Clinical milestones for four lead Biclonics® programs expected in 2019Cash expected to be sufficient to fund operations into the second quarter of 2021 UTRECHT, The Netherlands, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS).....»»
Amarillo Provides Business Update and Announces Third Quarter 2018 Financial Results
Completed the repayment in early Q3 2018 of the USD $8.5M gold linked credit fa.....»»
Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
Highlights Include FDA Approval of Phase 2 On-Ambulance Clinical Trial for Treatment of Stroke and Appointment of New Chief Financial Off.....»»
EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmac.....»»
Fennec Provides Business Update and Announces Third Quarter 2018 Financial Results
Positive Opinion on the Pediatric Investigation Plan from EMA for PEDMARKTM Targeting US approval of PEDMARKTM in the second half of 2019 Strong financial position with $24.5 million in cash and no .....»»
Reata Pharmaceuticals, Inc. Announces Third Quarter 2018 Financial Results and an Update on Development Programs
Reata Pharmaceuticals, Inc. Announces Third Quarter 2018 Financial Results and an Update on Development Programs.....»»
Marinus Pharmaceuticals Provides Business Update and Third Quarter 2018 Financial Results
RADNOR, Pa., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) ("Marinus" or "Company").....»»
InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update
InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update.....»»
AGTC Announces Financial Results and Business Update for the Fourth Quarter and Fiscal Year Ended June 30, 2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Tech.....»»
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2018 Financial Results and Business Update on September 13, 2018
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2018 Financial Results and Business Update on September 13, 2018.....»»
CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results
CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results - China FDA (CFDA) import drug re.....»»
VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update
VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update PR Newswire ISNES, Belgium, Aug. 13, 2018 ISNES, Belgium, Aug. 13, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition") today announced financi.....»»
Diffusion Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
Enrollment continues in Phase 3 GBM brain cancer trial Key European patent validated covering oral formulation of TSC Preparing for Phase 2 stroke trial with in-am.....»»
Fennec Provides Business Update and Announces Second Quarter 2018 Financial Results
Fennec Provides Business Update and Announces Second Quarter 2018 Financial Results.....»»
EyeGate Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
WALTHAM, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage, specialty pharmac.....»»